[91]
The respondent submits that the S(-) enantiomer of ofloxacin was inherently disclosed in the ofloxacin '840 patent in May 1984 and that before 1984, the breakdown of enantiomers from a racemic compound was "routine" and did not involve the exercise of any inventiveness.